• Justin M. Hall
    3/21/12 2:05P ET: [ IBB ] When IBB hits $122, it's time to get short. Consider playing BIS. I continue to like this play at/below $24.
    3/21/12
    Reply (5)
    • Justin M. Hall: Patience required for short biotech play. Buy & build positions over time. Sooner than later, IBB will come down & BIS will climb higher.
      3/21/12
    • Justin M. Hall: Avoid IBB puts as they are, like many biotech stock opitons, way overpriced. Short IBB directly at $122 or buy BIS at/near $24.
      3/21/12
    • The Chairman: A problem with BIS is its liquidity. Its daily volume averages around 2.0k. Difficult to exit a large position quickly when required.
      3/22/12
    • Justin M. Hall: It might require some work. We did very well with it last year. No BS. I like BIS right here and now.
      3/22/12
    • Justin M. Hall: [BIS] Going forward, I firmly believe it'll prove to be a solid bet. So, let's see how it plays out.
      3/22/12
      From other sites